A randomized phase 2 trial of apatinib vs observation as maintenance treatment following firstline induction chemotherapy in extensive stage small cell lung cancer-Reference-Cited by-同舟云学术

A randomized phase 2 trial of apatinib vs observation as maintenance treatment following firstline induction chemotherapy in extensive stage small cell lung cancer

Published:2019-08-09 Issue:1 Volume:38 Page:148-159
ISSN:0167-6997
Container-title:Investigational New Drugs
language:en
Short-container-title:Invest New Drugs

Author:

Luo Hao,Zhang Liang,Yang Bo,Feng Yan,Xiong Yanli,Zhang Shiheng,Li Xuemei,Qian Chengyuan,Dong Wang,Dai Nan

Funder

Major Research Plan

special project of social undertakings and social security innovation in Chongqing

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10637-019-00828-x.pdf

Reference43 articles.

1. Liu B, Qin J, Zhou J (2017) Advances in the treatment of relapsed small cell lung cancer. Zhongguo Fei Ai Za Zhi 20(3):192–198. https://doi.org/10.3779/j.issn.1009-3419.2017.03.08

2. Thatcher N (2002) New drugs in small cell lung cancer. Suppl Tumori 1(4):S26–S27

3. Lara PN Jr, Natale R, Crowley J, Lenz HJ, Redman MW, Carleton JE, Jett J, Langer CJ, Kuebler JP, Dakhil SR, Chansky K, Gandara DR (2009) Phase III trial of irinotecan/cisplatin compared with etoposide/cisplatin in extensive-stage small-cell lung cancer: clinical and pharmacogenomic results from SWOG S0124. J Clin Oncol 27(15):2530–2535. https://doi.org/10.1200/JCO.2008.20.1061

4. Horn L, Castellanos EL, Johnson DH (2011) Update on new drugs in small cell lung cancer. Expert Opin Investig Drugs 20(4):441–445. https://doi.org/10.1517/13543784.2011.553185

5. Folkman J (2002) Role of angiogenesis in tumor growth and metastasis. Semin Oncol 29(6 Suppl 16):15–18. https://doi.org/10.1053/sonc.2002.37263

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of Efficacy and Safety in First‐Line Treatment Methods for Extensive‐Stage Small Cell Lung Cancer: A Comprehensive Comparative Study of Chemotherapy, Targeted Therapy Combined With Chemotherapy, and Immunotherapy Combined With Chemotherapy;The Clinical Respiratory Journal;2024-08

2. Sintilimab plus anlotinib as second or further-line therapy for extensive disease small cell lung cancer: a phase 2 investigator-initiated non-randomized controlled trial;eClinicalMedicine;2024-04

3. Systemic Therapy for Small-Cell Lung Cancer: ASCO-Ontario Health (Cancer Care Ontario) Guideline;Journal of Clinical Oncology;2023-12-10

4. Novel Therapeutic Options for Small Cell Lung Cancer;Current Oncology Reports;2023-10-23

5. Therapeutic effectiveness of anlotinib combined with etoposide in extensive-stage small-cell lung cancer: a single-arm, phase II trial;Investigational New Drugs;2023-10-14